Advertisement

Are dual-chamber implantable cardioverter-defibrillators really better than single-chamber ones? A systematic review and meta-analysis

  • Bing-Wei Chen
  • Qing Liu
  • Xu Wang
  • Ai-Min Dang
Article

Abstract

Purpose

Although dual-chamber (DC) cardioverter defibrillators (ICDs) offer theoretical advantage over single-chamber (SC) ICDs, clinical studies showed conflicting results. The aim of this systematic review and meta-analysis was to compare DC and SC ICDs.

Methods

A systematic search of publications in PubMed, Embase, and the Cochrane Library without language restriction was performed. Randomized or nonrandomized controlled studies that compared DC and SC ICDs were included.

Results

Six randomized studies including 2,388 patients and 14 nonrandomized studies including 113,931 patients were identified. No difference in mortality was observed between DC and SC ICDs recipients in randomized studies. In nonrandomized studies, higher mortality was shown in DC group. There was no difference in the rate of inappropriate therapy between the DC and SC group after pooling the results from randomized studies as well as nonrandomized studies. More complications were observed with DC ICDs recipients.

Conclusions

DC ICDs showed no conclusive superiority over SC ICDs. Without indications for antibradycardia therapy, SC ICDs seem to be the preferred selection.

Keywords

Single-chamber ICD Dual-chamber ICD Mortality Complication Meta-analysis 

Notes

Conflict of interest

None declared

References

  1. 1.
    Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352(3), 225–237.PubMedCrossRefGoogle Scholar
  2. 2.
    The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine, 337(22), 1576–1583.CrossRefGoogle Scholar
  3. 3.
    Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346(12), 877–883.PubMedCrossRefGoogle Scholar
  4. 4.
    Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999). A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. New England Journal of Medicine, 341(25), 1882–1890.PubMedCrossRefGoogle Scholar
  5. 5.
    Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., et al. (2000). Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 101(11), 1297–1302.PubMedCrossRefGoogle Scholar
  6. 6.
    Theuns, D. A., Klootwijk, A. P., Goedhart, D. M., & Jordaens, L. J. (2004). Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. Journal of the American College of Cardiology, 44(12), 2362–2367.PubMedCrossRefGoogle Scholar
  7. 7.
    Friedman, P. A., McClelland, R. L., Bamlet, W. R., Acosta, H., Kessler, D., Munger, T. M., et al. (2006). Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation, 113(25), 2871–2879.PubMedCrossRefGoogle Scholar
  8. 8.
    Olshansky, B., Day, J. D., Moore, S., Gering, L., Rosenbaum, M., McGuire, M., et al. (2007). Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study. Circulation, 115(1), 9–16.PubMedCrossRefGoogle Scholar
  9. 9.
    Pedersen, S. S., van den Berg, M., Jordaens, L., van Son, J., & Theuns, D. A. (2009). Increased anxiety in partners of patients with a cardioverter-defibrillator: the role of indication for ICD therapy, shocks, and personality. Pacing and Clinical Electrophysiology, 32(2), 184–192.PubMedCrossRefGoogle Scholar
  10. 10.
    Sears, S. F., Lewis, T. S., Kuhl, E. A., & Conti, J. B. (2005). Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics, 46(5), 451–457.PubMedCrossRefGoogle Scholar
  11. 11.
    Poole, J. E., Johnson, G. W., Hellkamp, A. S., Anderson, J., Callans, D. J., Raitt, M. H., et al. (2008). Prognostic importance of defibrillator shocks in patients with heart failure. New England Journal of Medicine, 359(10), 1009–1017.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Daubert, J. P., Zareba, W., Cannom, D. S., McNitt, S., Rosero, S. Z., Wang, P., et al. (2008). Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. Journal of the American College of Cardiology, 51(14), 1357–1365.PubMedCrossRefGoogle Scholar
  13. 13.
    van Rees, J. B., Borleffs, C. J., de Bie, M. K., Stijnen, T., van Erven, L., Bax, J. J., et al. (2011). Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. Journal of the American College of Cardiology, 57(5), 556–562.PubMedCrossRefGoogle Scholar
  14. 14.
    Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., et al. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. European Heart Journal, 27(17), 2099–2140.PubMedCrossRefGoogle Scholar
  15. 15.
    Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A., 3rd, Freedman, R. A., Gettes, L. S., et al. (2013). 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation, 127(3), e283–352.PubMedCrossRefGoogle Scholar
  16. 16.
    Theuns, D. A., Rivero-Ayerza, M., Boersma, E., & Jordaens, L. (2008). Prevention of inappropriate therapy in implantable defibrillators: a meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. International Journal of Cardiology, 125(3), 352–357.PubMedCrossRefGoogle Scholar
  17. 17.
    Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. BMJ, 327(7414), 557–560.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Dewland, T. A., Pellegrini, C. N., Wang, Y., Marcus, G. M., Keung, E., & Varosy, P. D. (2011). Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. Journal of the American College of Cardiology, 58(10), 1007–1013.PubMedCrossRefGoogle Scholar
  19. 19.
    Wilkoff, B. L., Cook, J. R., Epstein, A. E., Greene, H. L., Hallstrom, A. P., Hsia, H., et al. (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA, 288(24), 3115–3123.PubMedCrossRefGoogle Scholar
  20. 20.
    Kolb, C., Deisenhofer, I., Schmieder, S., Barthel, P., Zrenner, B., Karch, M. R., et al. (2006). Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators. Pacing and Clinical Electrophysiology, 29(9), 946–952.PubMedCrossRefGoogle Scholar
  21. 21.
    Almendral, J., Arribas, F., Wolpert, C., Ricci, R., Adragao, P., Cobo, E., et al. (2008). Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Europace, 10(5), 528–535.PubMedCrossRefGoogle Scholar
  22. 22.
    Forleo, G. B., Vecchio, F., Papavasileiou, L., Mahfouz, K., Topa, A., Ticchi, C., et al. (2011). Clinical outcomes in implanted cardioverter defibrillator population: single chamber vs dual chamber. PACE-Pacing and Clinical Electrophysiology, 34(11), 1417–1418.Google Scholar
  23. 23.
    Mohammed, A. A., Bhat, P. K., Unsdorfer, K., & Costantini, O. (2011). Single versus dual chamber implantable cardioverter defibrillators: are single chamber devices really obsolete? Journal of the American College of Cardiology, 57(14), E15.CrossRefGoogle Scholar
  24. 24.
    Takahashi, T., Bhandari, A. K., Watanuki, M., Cannom, D. S., Sakurada, H., & Hiraoka, M. (2002). High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. Circulation Journal, 66(8), 746–750.PubMedCrossRefGoogle Scholar
  25. 25.
    Lee, D. S., Krahn, A. D., Healey, J. S., Birnie, D., Crystal, E., Dorian, P., et al. (2010). Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. Journal of the American College of Cardiology, 55(8), 774–782.PubMedCrossRefGoogle Scholar
  26. 26.
    Kuhlkamp, V., Dornberger, V., Mewis, C., Suchalla, R., Bosch, R. F., & Seipel, L. (1999). Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing. Journal of Cardiovascular Electrophysiology, 10(7), 905–915.PubMedCrossRefGoogle Scholar
  27. 27.
    Berenbom, L. D., Weiford, B. C., Vacek, J. L., Emert, M. P., Hall, W. J., Andrews, M. L., et al. (2005). Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II. Annals of Noninvasive Electrocardiology, 10(4), 429–435.PubMedCrossRefGoogle Scholar
  28. 28.
    Bagherzadeh, A., Emkanjoo, Z., Haghjoo, M., Farahani, M. M., Alizadeh, A., & Sadr-Ameli, M. A. (2006). Complications and mortality of single versus dual chamber implantable cardioverter defibrillators. Indian Pacing Electrophysiol Journal, 6(2), 75–83.Google Scholar
  29. 29.
    Soundarraj, D., Thakur, R. K., Gardiner, J. C., Khasnis, A., & Jongnarangsin, K. (2006). Inappropriate ICD therapy: does device configuration make a difference. Pacing and Clinical Electrophysiology, 29(8), 810–815.PubMedCrossRefGoogle Scholar
  30. 30.
    Jodko, L., Kornacewicz-Jach, Z., Kazmierczak, J., Rzeuski, R., Zielonka, J., Kaliszczak, R., et al. (2009). Inappropriate cardioverter-defibrillator discharge continues to be a major problem in clinical practice. Cardiology Journal, 16(5), 432–439.PubMedGoogle Scholar
  31. 31.
    Gold, M. R., Ahmad, S., Browne, K., Berg, K. C., Thackeray, L., & Berger, R. D. (2012). Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial. Heart Rhythm, 9(3), 370–377.PubMedCrossRefGoogle Scholar
  32. 32.
    Ruwald, A. C., Sood, N., Ruwald, M. H., Jons, C., Clyne, C. A., McNitt, S., et al. (2013). Frequency of inappropriate therapy in patients implanted with dual- versus single-chamber ICD devices in the ICD arm of MADIT-CRT. Journal of Cardiovascular Electrophysiology, 24, 672–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Weeke, P., Johansen, J. B., Jorgensen, O. D., Nielsen, J. C., Moller, M., Videbaek, R., et al. (2013). Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register. Europace, 15, 1150–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Peterson, P. N., Varosy, P. D., Heidenreich, P. A., Wang, Y., Dewland, T. A., Curtis, J. P., et al. (2013). Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA, 309(19), 2025–2034.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Deisenhofer, I., Kolb, C., Ndrepepa, G., Schreieck, J., Karch, M., Schmieder, S., et al. (2001). Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. Journal of Cardiovascular Electrophysiology, 12(2), 134–142.PubMedCrossRefGoogle Scholar
  36. 36.
    Koneru, J. N., Swerdlow, C. D., Wood, M. A., & Ellenbogen, K. A. (2011). Minimizing inappropriate or “unnecessary” implantable cardioverter-defibrillator shocks: appropriate programming. Circulation. Arrhythmia and Electrophysiology, 4(5), 778–790.PubMedCrossRefGoogle Scholar
  37. 37.
    Jastrzebski, M., Kukla, P., Czarnecka, D., & Kawecka-Jaszcz, K. (2012). Comparison of five electrocardiographic methods for differentiation of wide QRS-complex tachycardias. Europace, 14(8), 1165–1171.PubMedCrossRefGoogle Scholar
  38. 38.
    Tops, L. F., Schalij, M. J., & Bax, J. J. (2009). The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. Journal of the American College of Cardiology, 54(9), 764–776.PubMedCrossRefGoogle Scholar
  39. 39.
    Gasparini, M., Proclemer, A., Klersy, C., Kloppe, A., Lunati, M., Ferrer, J. B., et al. (2013). Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA, 309(18), 1903–1911.PubMedCrossRefGoogle Scholar
  40. 40.
    Moss, A. J., Schuger, C., Beck, C. A., Brown, M. W., Cannom, D. S., Daubert, J. P., et al. (2012). Reduction in inappropriate therapy and mortality through ICD programming. New England Journal of Medicine, 367(24), 2275–2283.PubMedCrossRefGoogle Scholar
  41. 41.
    McAuley, L., Pham, B., Tugwell, P., & Moher, D. (2000). Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet, 356(9237), 1228–1231.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Bing-Wei Chen
    • 1
    • 2
  • Qing Liu
    • 1
    • 2
  • Xu Wang
    • 1
    • 2
  • Ai-Min Dang
    • 1
    • 2
  1. 1.Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular DiseasesChinese Academy of Medical SciencesBeijingPeople’s Republic of China
  2. 2.Peking Union Medical CollegeBeijingChina

Personalised recommendations